W
WAVEMAN · COMPANY
III · Information Services Group Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

III

Information Services Group Inc.
PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001371489
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
1
13F, latest reported quarter
REVENUE GROWTH
-1.2%
XBRL, annual
NET MARGIN
3.8%
CONVERSIONS · 180D
3
codes C/M, not in net · no price filed
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
no Form 4 purchases or sales on file
CONGRESS
no member of Congress has reported trading it
FUNDS
1 fund added or opened last quarter
REVENUE
-1.2% year over year
below 59% of Pharma & Biotech
MARGIN
3.8% net margin
more than 72% of Pharma & Biotech
BUYBACKS
$1.3M repurchased, FY to 2026-06-30
below 88% of Pharma & Biotech
SHORT
1.6% of shares outstanding short · 4.1 days to cover · settled 2026-07-31
below 68% of Pharma & Biotech
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +1.3%
+1.3%12M
-25%-10%+5%+20%2025-092025-102025-122026-032026-052026-072026-09 2025-12-11 · Chevrillon & Associes sold $1.5M2025-11-07 · CONNORS MICHAEL P sold $1.4M2025-12-15 · Chevrillon & Associes sold $1.2M2025-11-11 · CONNORS MICHAEL P sold $521.5K2025-11-10 · CONNORS MICHAEL P sold $409.6K2025-11-12 · CONNORS MICHAEL P sold $348.2K
INSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows 1 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for Information Services Group Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Chevrillon & Associes
SELL
2025-12-15
200,000.0
$1.2M
Chevrillon & Associes
SELL
2025-12-11
250,000.0
$1.5M
CONNORS MICHAEL P
CHAIRMAN & CEO
SELL
2025-11-12
66,196.0
$348.2K
CONNORS MICHAEL P
CHAIRMAN & CEO
SELL
2025-11-11
100,096.0
$521.5K
CONNORS MICHAEL P
CHAIRMAN & CEO
SELL
2025-11-10
78,476.0
$409.6K
44 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 39 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
Legato Capital Management LLC
374,340.0 sh
$1.5M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Executive pay vs shareholder return · Michael Connors
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2023
$2.9M
$2.9M
$890.7K
+101%
-40%
2022
$4.2M
$148.1K
$1.2M
+89%
-30%
2021
$5.2M
$12.3M
$1.2M
+205%
+25%
2020
$3.3M
$4.4M
$1.0M
+30%
+19%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$244.7M$247.6M$291.1M$286.3M
OPERATING INCOME$17.8M$5.8M$14.6M$29.5M
NET INCOME$9.3M$2.8M$6.2M$19.7M
EPS (DILUTED)0.190.060.120.39
OPERATING CASH FLOW$29.0M$19.9M$12.3M$11.1M
CASH$28.7M$23.1M$22.6M$30.6M
LONG-TERM DEBT$59.2M$59.2M$79.2M$74.4M
BUYBACKS$9.3M$5.6M$3.5M$12.1M
DIVIDENDS PAID$9.2M$9.4M$8.7M$7.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →